Diagnostic Multicenter Phase II Study, Prospective, Comparative, of 68Ga-HBED-PSMA PET / CT and Conventional Imaging Procedures in Occult Biological Relapse Prostate Cancer
Phase of Trial: Phase II
Latest Information Update: 01 Jun 2018
At a glance
- Drugs Gallium 68 PSMA (Primary)
- Indications Prostate cancer
- Focus Diagnostic use
- Acronyms PSMA REBIOLOC
- 31 Aug 2018 Biomarkers information updated
- 29 May 2018 Planned End Date changed from 29 Sep 2018 to 29 Sep 2019.
- 29 May 2018 Planned primary completion date changed from 15 Apr 2018 to 31 Mar 2019.